Market Price

21.76 

-0.04 -0.2%

as of Apr 18 '19

52 Week Range:

20.21 38.80


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture products. The company operates in two segments, Domestic and International. Its products include steel, wood, laminate furniture, fume hoods, biological safety cabinets, laminar flow and ductless hoods, adaptable modular and column systems, moveable workstations and carts, epoxy resin worksurfaces, sinks, and accessories and related design services. The company's laboratory products are used in chemistry, physics, biology, and other general science laboratories in the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, government, and health care markets; technical products are used in facilities manufacturing computers and light electronics and by users of computer and networking furniture; and laminate caseworks that are used in educational, healthcare, and industrial applications. The company sells its products primarily through dealers, commissioned agents, and a national distributor, as well as through competitive bids submitted by the company and its subsidiaries in Singapore, India, and China. Kewaunee Scientific Corporation was founded in 1906 and is headquartered in Statesville, North Carolina.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Apr '08 Apr '09 Apr '10 Apr '11 Apr '12 Apr '13 Apr '14 Apr '15 Apr '16 Apr '17 Apr '18
Equity (BVPS) 10.56
10.54
11.83
12.10
11.44
11.90
12.08
13.64
13.60
14.87
16.71
growth rate -0.2% 12.2% 2.3% -5.5% 4.0% 1.5% 12.9% -0.3% 9.3% 12.4%
Earnings BIT 5.37
6.78
5.67
2.96
2.54
5.22
5.96
5.23
6.38
6.54
9.09
growth rate 26.3% -16.4% -47.8% -14.2% 105.5% 14.3% -12.4% 22.0% 2.6% 38.9%
Avg.PE 12.72
5.66
9.51
15.50
21.51
11.15
11.33
12.47
13.73
12.90
19.34
growth rate -55.5% 68.0% 63.0% 38.8% -48.2% 1.6% 10.1% 10.1% -6.1% 49.9%
ROA 6.54
8.24
6.55
3.09
1.62
4.58
5.93
5.34
5.36
5.89
6.28
growth rate 26.0% -20.5% -52.8% -47.6% 182.7% 29.5% -10.0% 0.4% 9.9% 6.6%
ROE 12.29
15.76
12.45
5.98
3.38
9.95
11.87
10.25
10.40
11.13
11.54
growth rate 28.2% -21.0% -52.0% -43.5% 194.4% 19.3% -13.7% 1.5% 7.0% 3.7%
ROIC 10.39
13.63
10.72
5.13
3.28
8.03
9.88
8.74
8.92
9.86
10.48
growth rate 31.2% -21.4% -52.2% -36.1% 144.8% 23.0% -11.5% 2.1% 10.5% 6.3%
Cur. Ratio 1.92
2.01
2.09
2.09
2.15
2.14
2.68
2.32
2.43
2.22
2.30
growth rate 4.7% 4.0% 0.0% 2.9% -0.5% 25.2% -13.4% 4.7% -8.6% 3.6%
Quick Ratio 1.38
1.50
1.51
1.46
1.45
1.43
1.84
1.52
1.58
1.57
1.54
growth rate 8.7% 0.7% -3.3% -0.7% -1.4% 28.7% -17.4% 4.0% -0.6% -1.9%
Leverage 1.87
1.95
1.86
2.00
2.17
2.17
1.85
1.99
1.89
1.89
1.79
growth rate 4.3% -4.6% 7.5% 8.5% 0.0% -14.8% 7.6% -5.0% 0.0% -5.3%
Balance Sheet Apr '08 Apr '09 Apr '10 Apr '11 Apr '12 Apr '13 Apr '14 Apr '15 Apr '16 Apr '17 Apr '18
Acct.Receivable 20.09
0.00
0.00
0.00
23.18
26.54
23.47
29.11
27.84
29.89
32.66
growth rate -100.0% 14.5% -11.6% 24.0% -4.4% 7.4% 9.3%
Acct.Payable 11.83
14.43
8.54
11.23
11.72
12.00
14.75
growth rate 22.0% -40.8% 31.5% 4.4% 2.3% 23.0%
Cur.Assets 33.18
37.50
38.60
42.40
42.82
47.23
43.35
48.76
50.96
59.81
63.50
growth rate 13.0% 2.9% 9.8% 1.0% 10.3% -8.2% 12.5% 4.5% 17.4% 6.2%
Total Assets 50.61
52.50
56.60
63.10
63.36
68.74
62.72
69.49
72.41
80.92
84.36
growth rate 3.7% 7.8% 11.5% 0.4% 8.5% -8.8% 10.8% 4.2% 11.8% 4.3%
Cash 3.78
3.60
1.70
2.40
6.89
6.50
6.25
3.04
5.22
12.51
9.72
growth rate -4.8% -52.8% 41.2% 187.2% -5.7% -3.9% -51.3% 71.6% 139.5% -22.3%
Inventory 6.98
7.80
8.40
10.50
11.76
13.20
11.94
12.75
15.63
14.94
17.66
growth rate 11.8% 7.7% 25.0% 12.0% 12.3% -9.6% 6.8% 22.6% -4.4% 18.3%
Cur.Liabilities 17.26
18.70
18.50
20.30
19.47
22.12
16.16
21.06
20.95
26.93
27.56
growth rate 8.3% -1.1% 9.7% -4.1% 13.6% -26.9% 30.3% -0.5% 28.5% 2.4%
Liabilities 23.66
25.60
26.20
31.60
33.85
37.07
28.49
34.29
33.85
37.66
36.84
growth rate 8.2% 2.3% 20.6% 7.1% 9.5% -23.1% 20.4% -1.3% 11.2% -2.2%
LT Debt 0.15
0.20
0.10
3.70
3.47
3.27
4.19
3.77
3.35
2.43
growth rate 33.3% -50.0% 3,600.0% -6.3% -5.8% 28.3% -10.0% -11.2% -27.4%
Equity 26.95
27.00
30.40
31.50
29.51
31.68
33.96
34.88
38.24
42.88
47.06
growth rate 0.2% 12.6% 3.6% -6.3% 7.3% 7.2% 2.7% 9.7% 12.1% 9.7%
Common Shares 3.00
3.00
3.00
3.00
3.00
3.00
3.00
3.00
3.00
3.00
3.00
growth rate 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Cash Flow Statement Apr '08 Apr '09 Apr '10 Apr '11 Apr '12 Apr '13 Apr '14 Apr '15 Apr '16 Apr '17 Apr '18
Capital Expenditures 2.55
1.50
4.24
5.25
1.44
2.41
2.02
2.57
2.19
2.61
growth rate -41.2% 182.7% 23.8% -72.7% 67.6% -16.0% 27.1% -14.8% 19.4%
Cash Dividends 0.71
0.80
1.40
1.00
1.03
1.78
1.12
1.23
1.36
1.57
growth rate 12.7% 75.0% -28.6% 3.1% 72.6% -36.9% 10.0% 10.3% 15.4%
Cash From OA 3.39
2.10
4.50
1.30
6.92
3.83
8.07
2.29
7.27
11.66
growth rate -38.1% 114.3% -71.1% 432.5% -44.7% 110.8% -71.6% 217.4% 60.4%
FCF per Share 0.33
0.23
0.11
-0.08
2.13
2.39
1.24
1.74
-1.14
2.69
1.03
growth rate -30.3% -52.2% -100.0% 100.0% 12.2% -48.1% 40.3% -100.0% 100.0% -61.7%
Sale Purchase of Stock 0.09
0.03
0.48
0.19
growth rate -64.1% 1,351.5% -60.3%
FCF 1.00
1.00
0.30
-4.00
5.00
1.00
6.00
-0.28
5.00
9.00
growth rate 0.0% -70.0% -100.0% 100.0% -80.0% 500.0% -100.0% 100.0% 80.0%
Income Statement Apr '08 Apr '09 Apr '10 Apr '11 Apr '12 Apr '13 Apr '14 Apr '15 Apr '16 Apr '17 Apr '18
Sales 89.51
104.00
99.10
100.00
102.85
117.12
111.17
118.83
128.63
138.56
158.05
growth rate 16.2% -4.7% 0.9% 2.9% 13.9% -5.1% 6.9% 8.3% 7.7% 14.1%
Op.Income 5.61
7.10
5.80
3.20
1.03
3.04
5.96
5.23
6.38
6.54
9.09
growth rate 26.6% -18.3% -44.8% -67.8% 195.3% 95.9% -12.4% 22.0% 2.6% 38.9%
IBT 5.37
6.80
5.70
3.00
2.54
5.22
5.99
5.39
5.74
6.75
9.48
growth rate 26.6% -16.2% -47.4% -15.4% 105.6% 14.7% -10.0% 6.6% 17.6% 40.5%
Net Income 3.13
4.20
3.60
1.90
1.03
3.04
3.90
3.53
3.80
4.52
5.19
growth rate 34.2% -14.3% -47.2% -45.7% 195.3% 28.0% -9.4% 7.7% 18.8% 14.9%
EPS 1.23
1.66
1.39
0.72
0.40
1.17
1.48
1.33
1.42
1.66
1.87
growth rate 35.0% -16.3% -48.2% -44.4% 192.5% 26.5% -10.1% 6.8% 16.9% 12.7%
Gross Profit 19.17
21.40
21.40
19.30
19.16
22.26
22.03
21.77
23.71
26.61
32.02
growth rate 11.6% 0.0% -9.8% -0.8% 16.2% -1.0% -1.2% 8.9% 12.2% 20.3%

Quarterly Statements

Item Name Apr '17 Jul '17 Oct '17 Jan '18 Apr '18
Earnings BIT 1.89
1.69
2.66
2.38
2.36
growth rate -10.6% 57.3% -10.2% -1.0%
Balance Sheet Apr '17 Jul '17 Oct '17 Jan '18 Apr '18
Acct.Receivable 29.89
23.64
33.25
30.84
32.66
growth rate -20.9% 40.7% -7.2% 5.9%
Acct.Payable 16.61
11.93
14.36
12.63
14.75
growth rate -28.2% 20.4% -12.1% 16.8%
Cur.Assets 59.81
55.68
64.76
62.28
63.50
growth rate -6.9% 16.3% -3.8% 2.0%
Total Assets 80.92
76.56
85.87
82.69
84.36
growth rate -5.4% 12.2% -3.7% 2.0%
Cash 13.94
12.02
11.79
9.18
9.72
growth rate -13.8% -1.9% -22.2% 5.9%
Inventory 14.94
17.00
16.44
17.68
17.66
growth rate 13.8% -3.3% 7.6% -0.1%
Cur.Liabilities 26.93
21.61
30.51
26.05
27.56
growth rate -19.7% 41.2% -14.6% 5.8%
Liabilities 38.03
32.38
40.55
36.60
36.84
growth rate -14.9% 25.2% -9.7% 0.6%
LT Debt 2.43
2.14
1.85
1.56
growth rate -12.0% -13.6% -15.8%
Equity 42.88
43.77
44.94
45.67
47.06
growth rate 2.1% 2.7% 1.6% 3.0%
Common Shares 6.79
6.79
6.81
6.82
47.06
growth rate 0.0% 0.3% 0.2% 589.9%
Cash Flow Statement Apr '17 Jul '17 Oct '17 Jan '18 Apr '18
Capital Expenditures 0.42
0.44
1.00
0.47
growth rate 3.3% 130.3% -53.1%
Cash Dividends 0.46
0.41
0.46
0.46
growth rate -12.3% 13.8% 0.2%
Cash From OA 5.81
0.53
-2.64
1.47
growth rate -90.9% -100.0% 100.0%
Sale Purchase of Stock -0.14
0.01
0.00
growth rate 100.0% -100.0%
FCF 5.39
0.10
-3.65
1.00
growth rate -98.2% -100.0% 100.0%
Income Statement Apr '17 Jul '17 Oct '17 Jan '18 Apr '18
Sales 34.58
33.88
41.47
38.19
44.51
growth rate -2.0% 22.4% -7.9% 16.5%
Op.Income 1.75
1.69
2.66
2.38
2.36
growth rate -3.6% 57.3% -10.2% -1.0%
IBT 1.83
1.80
2.74
2.48
2.46
growth rate -1.6% 52.6% -9.4% -1.1%
Net Income 1.39
1.15
1.72
0.88
1.43
growth rate -17.3% 50.2% -48.8% 62.3%
EPS
growth rate
Gross Profit 7.33
6.82
7.91
8.35
8.93
growth rate -7.0% 16.0% 5.6% 6.9%
R&D
growth rate

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

B (80.24)

YOY Growth Grade:

D (41.46)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 14.42 14.42 10.07
EPS / Growth -19.2% 1.51

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 8.0%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 1.0% 4.5% 4.5%
Future PE 2.00 11.15 11.15
Future EPS 1.67 2.34 2.34
Value Price
MOS %
0.82
-96.2%
6.45
-70.4%
6.45
-70.4%
MOS Price 0.41 3.22 3.22
IRT 13.41 10.98 10.98

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.